~~<i id='0E380918C9'><strike id='0E380918C9'><tt id='0E380918C9'><pre id='0E380918C9'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：knowledge 2025-10-02 08:20:08 Page View：5

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FAMU bans football players from facility after release of rap video shot in team's locker room
Next article： Jerome Adams on the need for new antivirals for Covid

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

FDA approves first blood sugar monitor without finger pricks

TheFDAhasapprovedadevicefromAbbottthatcontinuouslymonitorsdiabetics’bloodsugarlevelswithoutrequiring

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

5:50InthisApril22,2022,filephoto,WashingtonstateGovernorJayInsleespeakspriortoPresidentJoeBidenatGre